Background/aim: Dual-specificity protein phosphatase 4 (DUSP4) negatively regulates MAPK signaling and is involved in various cellular processes. We herein evaluated the relationship between DUSP4 expression and clinicopathological characteristics in a large series of gastric cancer samples. Materials and methods: DUSP4 expression was examined by immunohistochemistry in 508 gastric cancer samples. Cases were classified according to the TCGA molecular classification and HER2 amplification. Kaplan-Meier plots were used to predict the relationship between mRNA expression of DUSP4 and survival. Results: Low expression of DUSP4 was significantly correlated with larger tumor size, higher pT category, positive nodal status, higher stage, lymphov...
Several dual-specificity phosphatases (DUSPs) that play key roles in the direct or indirect inactiva...
Purpose: The present study investigated the clinical significance of transmembrane protease, serine ...
PURPOSE: The present study investigated the clinical significance of transmembrane protease, serine ...
Dual-specificity protein phosphatase 4 (DUSP4) is a negative regulator of mitogen-activated protein ...
Background: Chemotherapy is important component in the management of breast cancer. To achieved bett...
PurposeDual-specificity phosphatase 4 (DUSP4) inactivates factors in the mitogen-activated protein k...
As dual-specificity phosphatase (DUSP) expression has been correlated to sensitivity to MEK inhibito...
Background: Chemotherapy is important component in the management of breast cancer
Dual specificity phosphatase 4 (DUSP4), a member of the dual specificity phosphatase family, is resp...
Estrogen receptor (ER)-negative cancers have a poor prognosis, and few targeted therapies are availa...
Suppressive effects of DUSP6 in tumorigenesis and EMT-associated properties were observed. Dual-spec...
Osteosarcoma (OS) is the most frequent primary bone tumor that affect children and adolescents. This...
Background Dual specificity protein phosphatase (DUSP)12 is an atypical member of the protein tyrosi...
The majority of patients develop resistance against suppression of HER2-signaling mediated by tras...
In many ways cancer is a disease of cellular signalling disequilibrium. When the equilibrium of key ...
Several dual-specificity phosphatases (DUSPs) that play key roles in the direct or indirect inactiva...
Purpose: The present study investigated the clinical significance of transmembrane protease, serine ...
PURPOSE: The present study investigated the clinical significance of transmembrane protease, serine ...
Dual-specificity protein phosphatase 4 (DUSP4) is a negative regulator of mitogen-activated protein ...
Background: Chemotherapy is important component in the management of breast cancer. To achieved bett...
PurposeDual-specificity phosphatase 4 (DUSP4) inactivates factors in the mitogen-activated protein k...
As dual-specificity phosphatase (DUSP) expression has been correlated to sensitivity to MEK inhibito...
Background: Chemotherapy is important component in the management of breast cancer
Dual specificity phosphatase 4 (DUSP4), a member of the dual specificity phosphatase family, is resp...
Estrogen receptor (ER)-negative cancers have a poor prognosis, and few targeted therapies are availa...
Suppressive effects of DUSP6 in tumorigenesis and EMT-associated properties were observed. Dual-spec...
Osteosarcoma (OS) is the most frequent primary bone tumor that affect children and adolescents. This...
Background Dual specificity protein phosphatase (DUSP)12 is an atypical member of the protein tyrosi...
The majority of patients develop resistance against suppression of HER2-signaling mediated by tras...
In many ways cancer is a disease of cellular signalling disequilibrium. When the equilibrium of key ...
Several dual-specificity phosphatases (DUSPs) that play key roles in the direct or indirect inactiva...
Purpose: The present study investigated the clinical significance of transmembrane protease, serine ...
PURPOSE: The present study investigated the clinical significance of transmembrane protease, serine ...